刺激响应的核心--纳米载体用于植入物导向的磁性药物向
Timo Herrmann1,2, Nina Angrisani3,2, Janin Reifenrath3,2
1Institute of Inorganic Chemistry, Hannover, Germany. nina.ehlert@acb.uni-hannover.de.
Journal of materials chemistry. B
|May 20, 2025
概括
研究人员开发了新的磁纳米载体,用于向向植入感染的抗生素输送. 这些响应pH的纳米颗粒改善药物加载和控制释放,提高治疗效率.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 传染病研究 传染病研究
背景情况:
- 植入物相关感染带来了重大的临床挑战,需要先进的局部治疗策略.
- 当前的本地药物输送方法往往受到不受控制的药物释放和不良向的影响.
- 纳米孔和磁性氧化铁具有作为有效药物载体的潜力.
研究的目的:
- 开发一种新的核心外纳米载体系统,用于有针对性和可控的抗生素输送.
- 设计响应pH的药物释放,以提高感染部位的疗效.
- 为了提高纳米载体的稳定性和药物载荷能力,用于植入物感染.
主要方法:
- 制造磁性纳米多孔芯外纳米颗粒.
- 具有pH响应的聚合物外 (多2-乙胺) 乙烯基甲酸盐 - PDEMA) 的功能化.
- 用硫酸组修改纳米粒子孔表面,以提高稳定性和药物负载.
- 载入抗生素恩罗夫洛克萨并评估其释放特征.
主要成果:
- 成功合成了具有磁性准能力的核心--纳米载体.
- 已证实pH触发的恩罗夫洛克萨释放,对酸性感染环境有反应.
- 硫酸修饰改善了颗粒分散,恩罗夫洛克萨负载和调节的释放动力学.
- 与未经修改的系统相比,实现了增强的药物整合和受控释放.
结论:
- 开发的磁性,pH响应的纳米载体代表了治疗植入物相关感染的创新方法.
- 该系统提供了有针对性的输送和受控的抗生素释放,克服了传统疗法的局限性.
- 功能化策略增强了药物负载和稳定性,为更有效的局部治疗铺平了道路.
相关概念视频
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


